Ye HK, Zhang YM. [Research progress of mesenchymal stem cell-derived exosomes in liver diseases].
Zhonghua Gan Zang Bing Za Zhi 2022;
30:790-792. [PMID:
36038353 DOI:
10.3760/cma.j.cn501113-20220330-00154]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Exosomes can mediate cell-cell interactions by transporting various active substances such as nucleic acids, proteins, and lipids. Mesenchymal stem cell-derived exosomes (MSCs) can play important roles in promoting liver repair and regeneration through the active substances it carries, inhibiting liver inflammation and liver fibrosis, and regulating tumor progression, and thereby providing new therapeutic strategies for clinical liver diseases. This article reviews the research progress of MSCs-derived exosomes in liver diseases.
Collapse